InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Simon Barry J., Director. Insider active across 1 company, notably ImmunityBio, Inc.. Aggregated, 10 disclosures have been logged. Split: 0 buy · 5 sells. Total volume traded: €1.5m. Activity tracked since 5 May 2021. The latest transaction was disclosed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Simon Barry J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
25,000 sharesCommon StockSEC:0001647994-26-000011:0
75,000 shares@ US$12.01050.0091% mcap25.9% of flowCommon StockSEC:0001647994-26-000006:0
10,000 shares@ US$9.254.4% of flowCommon StockSEC:0001647994-26-000004:0
76,967 shares@ US$6.540.0052% mcap14.6% of flowCommon StockSEC:0001647994-26-000002:0
15,243 shares0Common StockSEC:0001326110-25-000020:0
110,020 shares@ US$1.99846.7% of flowCommon StockSEC:0001326110-25-000006:0
57,200 shares0Common StockSEC:0001326110-24-000015:0
57,199 shares0Common StockSEC:0001326110-23-000113:0
14,990 shares@ US$16.08834.6% of flowCommon StockSEC:0001209191-21-035815:0
56,967 shares@ US$1.75444.7% of flowCommon StockSEC:0001209191-21-030886:0
10 of 10 declarations
About Simon Barry J.
Barry J. Simon is a Director at ImmunityBio, Inc. In this role, he participates in the governance of the company, contributing to strategic decision-making and oversight of operations. His expertise in the biopharmaceutical sector is valuable in guiding management and ensuring compliance with regulations. As a director, he plays a key role in developing the company's policies.
